ArticleCell death & disease2025
Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.
Rhynelle S Dmello, Michelle Palmieri, Pathum S Thilakasiri, Larissa Doughty, Tracy L Nero, Ashleigh R Poh, Sarah Q To, Erinna F Lee, W Douglas Fairlie, Lisa Mielke and 5 more
Abstract readPublished Erratum
In one paragraphArticle in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
15 authors.
Rhynelle S DmelloOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
Michelle PalmieriWalter and Eliza Hall Institute of Medical Research (WEHI), Parkville, VIC, 3010, Australia.
Pathum S ThilakasiriOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
Larissa DoughtyDepartment of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia.
Tracy L NeroDepartment of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-3393-1843 Sarah Q ToOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
Erinna F LeeOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.
Michael W ParkerDepartment of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-3101-1138 Ivan K H PoonDepartment of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3083, Australia.ORCID http://orcid.org/0000-0002-9119-7173 Ashwini L ChandOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia. ashwini.chand@onjcri.org.au.ORCID http://orcid.org/0000-0002-1245-729X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40355405
PMCPMC12069541
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390